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In Brief
Glycoprotein-deleted rabies virus is
widely used to trace neural circuits, but it
labels only a fraction of all presynaptic
neurons. Kim et al. provide a simple
method to increase transsynaptic tracing
efficiency by adopting the engineered
and optimized glycoprotein (oG).
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Monosynaptic rabies virus tracing is a unique and
powerful tool used to identify neurons making direct
presynaptic connections onto neurons of interest
across the entire nervous system. Current methods
utilize complementation of glycoprotein gene-
deleted rabies of the SAD B19 strain with its glyco-
protein, B19G, to mediate retrograde transsynaptic
spread across a single synaptic step. In most condi-
tions, this method labels only a fraction of input
neurons and would thus benefit from improved effi-
ciency of transsynaptic spread. Here, we report
newly engineered glycoprotein variants to improve
transsynaptic efficiency. Among them, oG (optimized
glycoprotein) is a codon-optimized version of a
chimeric glycoprotein consisting of the transmem-
brane/cytoplasmic domain of B19G and the extracel-
lular domain of rabies Pasteur virus strain glycopro-
tein. We demonstrate that oG increases the tracing
efficiency for long-distance input neurons up to 20-
fold compared to B19G. oG-mediated rabies tracing
will therefore allow identification and study of more
complete monosynaptic input neural networks.INTRODUCTION
Since its introduction in 2007, monosynaptic neural circuit
tracing using glycoprotein (G)-deleted rabies virus (RVdG) has
been a powerful and widely adopted tool for the study of neural
circuit organization and function (Callaway and Luo, 2015; Wick-
ersham et al., 2007b). Traditionally, the intact rabies virus has
been used as a retrograde transsynaptic tracer (Callaway,
2008; Ugolini, 2008). However, since the intact rabies spreads
across multiple synapses, it was challenging to identify clear
input and output relationships between rabies-labeled neurons.
By using RVdG and pseudotyping it with EnvA, it is possible to
target rabies virus infection to specific starter cell types of inter-
est or even single neurons and to transsynaptically label only
their direct presynaptic inputs throughout the mammalian brain
(Wickersham et al., 2007b). With this approach, G, which is
essential for the transsynaptic spread of rabies virus, is deleted
from the rabies genome and replaced by a transgene such as692 Cell Reports 15, 692–699, April 26, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://GFP. Consequently, RVdG infection is unable to spread except
when G is provided in trans. Following trans-complementation,
RVdG can utilize G to assemble functional rabies virus particles
(G+RVdG) that can spread retrogradely across synapses and
infect directly presynaptic neurons. The RVdG labels these pre-
synaptic neurons by expressing transgenes of interest, such as
GFP, but is unable to spread further due to the absence of
G. Due to its ability to spread across only one synaptic step in
the retrograde direction, RVdG has been used widely to delin-
eate brain-wide monosynaptic connectivity to populations of
neurons in both the central and peripheral nervous system (Call-
away and Luo, 2015).
One important limitation of current monosynaptic rabies
tracing is that only a fraction of presynaptic neurons are labeled
(Callaway and Luo, 2015). Several lines of evidence suggest that
G is a limiting factor (Callaway and Luo, 2015; Miyamichi et al.,
2013); for example, increasing levels of G expression by either
using a stronger promoter or using a cassette that expresses
only G both result in improved tracing efficiency (Miyamichi
et al., 2013; Watabe-Uchida et al., 2012). Therefore, improve-
ments in labeling might be achieved by increasing the efficiency
of packaging of G into rabies virus particles, improving the up-
take of rabies particles by presynaptic neurons, or increasing
levels of G expression in starter neurons. Improved efficiency
of transsynaptic spread using G-deleted rabies virus of the
CVS-N2C strain is consistent with these possibilities (Reardon
et al., 2016). Here, we attempt to optimize all three of these fac-
tors. We designed additional rabies glycoproteins and tested
their efficiency for trans-complementation and labeling of pre-
synaptic neurons. We then codon optimized the best of these
glycoproteins to maximize expression levels. This modified
rabies glycoprotein, oG, significantly improves the efficiency of
long-distance transsynaptic tracing with SAD B19 RVdG.RESULTS
To improve the current monosynaptic rabies virus tracing sys-
tem, we designed and engineered rabies glycoprotein variants
different from the original B19G. Various strains of rabies virus
display different degrees of virulence and pathogenicity associ-
ated with synaptic spread (Schnell et al., 2010). Previous studies
showed that retrograde infectivity and transsynaptic spread
could be improved in rabies glycoprotein pseudotyped lentivirus
or HEP-Flury dG rabies system by using G from different strains
of rabies (Kato et al., 2011b; Mori andMorimoto, 2014). Becausecreativecommons.org/licenses/by-nc-nd/4.0/).
BA Figure 1. Rabies Virus Glycoprotein from
SAD B19 Strain and Its Three Engineered
Variants
(A) Multiple protein sequence alignment for B19G,
PBG, and NBG. ‘‘*’’ indicates a single fully
conserved amino acid residue; ‘‘:’’ indicates con-
servation between amino acid groups of strongly
similar properties, whereas ‘‘.’’ indicates conser-
vationbetweenaminoacidgroupsofweaklysimilar
properties (the Gonnet PAM 250 matrix score >0.5
and% 0.5, respectively; Sievers et al., 2011).
(B) Schematic representation illustrating glyco-
protein from SAD B19 strain and three other
chimeric variants: NBG, PBG, and oG.
Non-highlighted sequences indicate the extracel-
lular domain, yellow highlighted sequences indi-
cate the stalk domain, red sequences indicate the
transmembrane domain, and green sequences
indicate the cytoplasmic domain of glycoproteins.G has a modular structure with distinct cytoplasmic and extra-
cellular domains, we reasoned that efficiency of synaptic uptake
would be most influenced by the extracellular domain but pack-
aging efficiency would be dependent on the cytoplasmic
domain. To maintain optimized packaging efficiency, we there-
fore engineered chimeric glycoproteins that incorporated the
B19G cytoplasmic domain (to match the SAD B19 RVdG) and
the extracellular domain from G of other strains of rabies virus.CeNBG (N2C G and B19G chimeric protein)
is a variant incorporating the extracellular
domain from the challenge virus standard
strain, CVS-N2C, whereas PBG (Pasteur
strain G and B19G chimeric protein) is a
variant incorporating the extracellular
domain from the Pasteur virus strain of
rabies (Kato et al., 2011a) (Figures 1A
and 1B). If uptake efficiency by presynap-
tic terminals is derived from differences in
amino acid sequences of extracellular
domains between three strains of rabies
(Figure 1A), transsynaptic efficiency
should be improved by incorporating
extracellular domains from other strains
having different pathogenicities. After
initial assessment of transsynaptic
spreading efficiency, we decided to
improve PBG further to produce oG (opti-
mized glycoprotein) via codon optimiza-
tion (Figures 1B and S1).
We made direct comparisons of in vivo
transsynaptic labeling efficiency using
the three chimeric glycoproteins, NBG,
PBG, oG, or the original B19G. We quan-
tified how many long-distance presynap-
tic neurons per postsynaptic neuron in
known circuits were traced using RVdG
in combination with each glycoprotein
variant. First, to utilize Cre recombinasetechnology to label and express genes in specific cell types,
we developed AAV helper virus expressing glycoprotein and
nuclear GFP (H2B-GFP) with the FLEX cassette in a Cre-depen-
dent manner (AAV-FLEX-H2B-GFP-2A-G). Co-expression of
nuclear GFP and glycoprotein enables us to label and count
the exact numbers of post-synaptic starter neurons (RVdG-in-
fected cells that also express G in trans) unambiguously. We
chose to examine retrograde labeling in two thalamic areas,ll Reports 15, 692–699, April 26, 2016 693
Figure 2. Monosynaptic Rabies Virus
Tracing of Inputs to PV Interneurons
Schematic illustration of the scheme for virus
infection and spread of rabies virus from PV
interneurons in primary visual cortex (V1) of
PVIRES-Cre/+;R26LSL-TVA/+ mouse.
(A) PVIRES-Cre/+;R26LSL-TVA/+ mice were injected in
V1 with AAV-FLEX-H2B-GFP-2A-G-WPRE. All PV
interneurons express TVA (blue), and those that
are starter cells also express nuclear GFP (H2B-
GFP) and rabies glycoprotein (G).
(B) After 2 or 3 weeks, EnvA+RVdG-dsRed was
injected into the same site in V1. EnvA+RVdG-
dsRed infects TVA-expressing PV interneurons
including starter cells.
(C) After 1week,monosynaptic input neurons to PV
starter neurons were labeled with dsRed+ due to
retrograde transsynaptic spread of rabies virus.the dorsal lateral geniculate nucleus (dLGN) and lateral posterior
nucleus (LP), that provide long-distance inputs to parvalbumin+
(PV+) interneurons in primary visual cortex (V1) of transgenic
mouse, PVIRES-Cre/+;R26LSL-TVA/+. In PVIRES-Cre/+;R26LSL-TVA/+
mice, Cre recombinase and the avian viral receptor TVA are ex-
pressed only in PV-expressing neurons, including PV-express-
ing inhibitory neurons in V1 (Figure 2A). At postnatal day 38–78
(P38–P78), we injected AAV-FLEX-H2B-GFP-2A-G into V1 of
PVIRES-Cre/+;R26LSL-TVA/+ mice. Although different versions of
AAV-FLEX-H2B-GFP-2A-G were used, each expressing a
different glycoprotein variant, all injections were matched for
viral titer (1.5 3 1012 GC/ml, except for oG, which was 1.15 3
1012 GC/ml) and injection volume (100 nl). Only AAV-infected
PV+ interneurons in V1 express nuclear GFP, glycoprotein, and
TVA (blue/green neurons; Figure 2A). Two or three weeks later,
we injected 200 nl EnvA-pseudotyped dsRed expressing rabies
virus (EnvA+RVdG-dsRed) into the same location (Figure 2B).
EnvA-pseudotyped rabies can infect only neurons expressing
its cognate receptor, TVA (PV+, TVA+ neurons), and primary
infection is therefore restricted to PV+ neurons. PV+ neurons in-
fected by both AAV helper and EnvA+RVdG-dsRed are desig-
nated as starter neurons and uniquely express both dsRed and
nuclear GFP. In starter neurons, RVdG-dsRed can assemble
functional virus particles due to trans-complementation with G,
and these particles can then spread monosynaptically and
retrogradely (Figure 2C). Seven days after rabies virus injections,
we harvested, sectioned, and stained the brains. dsRed+ input
neurons and dsRed+ GFP+ starter neurons were analyzed in
every section of thalamic regions and V1 for quantification,
respectively.
In all mouse brains included for analysis (Table S1), we
observed that nuclear GFP and dsRed neurons were spread
across the cortical layers within V1. Figure 3A shows examples
of experiments in which B19G or oG were expressed in starter
cells. We counted GFP+ dsRed+ neurons as PV+ starter neurons
(Figure 3B, white arrows in left four panels). Neither GFP+
dsRed nor GFP dsRed+ neurons were counted as starter
neurons, since lack of either GFP or dsRed indicates either
the absence of G or the absence of rabies infection in those
cells (Figure 3B, right four panels). We do not observe nuclear
GFP expression in PV cells, indicating that nuclear GFP694 Cell Reports 15, 692–699, April 26, 2016and G expression are tightly controlled and only expressed in
the PV-Cre+ neurons (Figure S2A). As a further control to
test for possible ‘‘leak’’ expression of TVA in neurons from
R26LSL-TVA/+ mice neurons in the absence of Cre, we injected
EnvA+RVdG-GFP or EnvA+RVdG-H2B-mCherry into the visual
cortex of PVIRES-Cre/+;R26LSL-TVA/+ or Tlx3-Cre/+; R26LSL-TVA/+
mice, respectively. Tlx3-Cre mice express Cre only in cortical
layer 5 pyramidal neurons (Gerfen et al., 2013). In both control
experiments, fluorescent reporters expressed from the rabies
genome were restricted to the Cre+ neurons, indicating that
expression of TVA in the absence of Cre, if any, was insufficient
to mediate infection with the EnvA+RVdG (Figures S2B and
S2C). The locations of starter neurons are similar between all
the experimental groups, since the coordinates of injection sites
were the same in all brains; all GFP+ dsRed+ starter neurons are
restricted to V1. The positions of starter neuron populations
along the anterior-posterior axis of the brains are also similar
(median 3.09 mm for B19G, 2.97 mm for NBG, 3.17 mm for
PBG, and 3.28 mm for oG, Kruskal-Wallis test with Dunn’s mul-
tiple comparisons test as a post hoc, p = 0.5288; Figure 3C, left).
Along the dorsoventral axis from pia to white matter, the distribu-
tions of starter neurons are also similar among the four groups
(Kruskal-Wallis test with Dunn’s multiple comparisons test as a
post hoc, p = 0.9992; Figure 3C, right). In addition, we did not
observe any effects of the ages of animals when AAV was in-
jected, the timing between AAV and rabies virus injections, or
the numbers of starter neurons on viral tracing efficiency (Pear-
son correlation analysis; Figure S3).
Next, we compared transsynaptic efficiency of rabies tracing
using B19G, NBG, and PBG. For most PVIRES-Cre/+;R26LSL-TVA/+
brains where we find GFP+ dsRed+ starter neurons in V1, we
observe that both dLGN and LP are prominent thalamic struc-
tures where long-distance inputs are reliably labeled (Figures
4A and 4B). To assess the transsynaptic spreading efficiency
to dLGN and LP, we calculated the convergence index for
each animal (Miyamichi et al., 2013). The convergence index is
calculated as the number of dsRed+ input neurons divided by
the number of GFP+ dsRed+ starter neurons. In dLGN, animals
in which PBG was used for trans-complementation displayed
significantly higher convergence indices compared to B19G
(0.214 ± 0.06 versus 0.069 ± 0.02 respectively, Mann-Whitney
AC
B
Figure 3. PV Starter Neuron Distributions in
Mouse V1
(A) Coronal sections of mouse V1 show starter
neurons expressing both GFP from AAV-FLEX-
H2B-GFP-2A-G and dsRed from EnvA+RVdG-
dsRed. Top panels illustrate a mouse V1 section
when B19G was used, whereas bottom panels
illustrate use of oG.
(B) Confocal images showing PV starter neurons
(left; white arrows indicate GFP+ dsRed+ a-PV+
neurons) and PV+ non-starter neurons (right; yel-
low arrowheads indicate GFP+ a-PV+ but dsRed
neurons)
(C) Starter cell distributions. (Left) The median
position of starter neuron populations expressed
as center of gravity along the anterior-posterior
axis for each of the four experimental groups
labeled according the glycoprotein used for trans-
complementation. Values (mm) indicate distances
posterior to bregma. Boxes extend from the 25th
to the 75th percentile. Whiskers indicate ranges
from smallest to largest values. There are no sta-
tistical differences between groups (Kruskal-
Wallis test with Dunn’s multiple comparisons test,
p = 0.5288). (Right) Distributions of starter neuron
proportions plotted according to distance from
pia to white matter (wm) (Kruskal-Wallis test with
Dunn’s multiple comparisons test, p = 0.9992).
Values are reported as mean ± SEM.
Scale bars represent 100 mm (A) or 10 mm (B).test, p < 0.05), whereas the convergence index for NBG was not
higher than that of B19G (0.042 ± 0.01 versus 0.069 ± 0.02
respectively, Mann-Whitney test; Figure 4B). In LP, animals in
which PBG was used for trans-complementation had a 2-fold
higher convergence index than with B19G (0.020 ± 0.01 versus
0.009 ± 0.01; Figure 4D), but this difference was not statistically
significant (Mann-Whitney test, p = 0.1113). The convergence in-
dex was significantly lower with NBG than with B19G (0.001 ±
0.00 versus 0.009 ± 0.01; Mann-Whitney test, p < 0.05;
Figure 4D).
Based on these comparisons, we conclude that PBG medi-
ates transsynaptic spread more efficiently than B19G, but NBG
does not. We therefore aimed to further improve transsynaptic
spread by increasing PBG expression levels via codon optimiza-Cetion. We named the codon-optimized
PBG, oG (optimized glycoprotein). We
expected that optimizing factors related
to codon usage, including codon usage
bias, GC content, and undesirable cis-
acting elements forMusmusculus, would
increase the expression level of glyco-
protein by at least 2-fold in our mouse
system (Genscript). We conducted in vivo
experiments using oG for trans-comple-
mentation and quantified the conver-
gence indices for dLGN and LP thalamic
inputs onto V1 PV+ neurons as described
above. Notably, comparisons between
PBG and oG showed that oG trans-complementation resulted in significantly higher convergence
indices in both dLGN (0.214 ± 0.06 versus 0.875 ± 0.21 for
PBG and oG respectively, Mann-Whitney test, p < 0.01) and
LP (0.020 ± 0.01 versus 0.179 ± 0.06 for PBG and oG respec-
tively, Mann-Whitney test, p < 0.001; Figures 4B and 4D, right).
When comparing convergence indices for oG versus the orig-
inal glycoprotein, SAD B19G, the difference is even more strik-
ing, demonstrating an improvement of more than 12-fold for
LGN labeling (0.875 ± 0.21 versus 0.069 ± 0.02 for oG and
SAD B19G) and nearly 20-fold for LP labeling (0.179 ± 0.06
versus 0.009 ± 0.01 for oG and SADB19G). In conclusion, our re-
sults demonstrate that oG is the most efficient of the glycopro-
teins tested and increases the efficiency of transsynaptic spread
by more than an order of magnitude compared to SAD B19G.ll Reports 15, 692–699, April 26, 2016 695
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Figure 4. Efficiency of Transsynaptic
Spread following trans-complementation
with Different Glycoproteins
(A and C) Coronal sections showing dsRed+
monosynaptic input neurons in dLGN (A) and LP
(C) to PV interneurons in V1 when using B19G (top)
and oG (bottom).
(B and D) Convergence indices for long-distance
presynaptic inputs in dLGN (B) and LP (D) when
using B19G, NBG, PBG, or oG rabies glycopro-
teins.
Values are reported as mean ± SEM. Statistics
were calculated from Mann-Whitney test for non-
parametric comparisons. Individual data points
(circles, squares or triangles) indicate values for
each animal. Significant differences between pairs
are indicated by the p value. *p < 0.05, **p < 0.01,
and ***p < 0.001. ns, not significant. Abbreviations
used: dLGN, dorsal lateral geniculate nucleus; LP,
lateral posterior thalamic nucleus. Scale bars,
100 mm (A and C).DISCUSSION
In this report, we investigated whether newly generated rabies
glycoprotein variants can improve the current monosynaptic
rabies tracing system by labeling a greater proportion of the neu-
rons that are presynaptic to starter neurons. Our results demon-
strated that a glycoprotein consisting of the extracellular domain
of Pasteur strain glycoprotein and the transmembrane/cyto-
plasmic domain of SAD B19 glycoprotein (PBG) improves
trans-complementation and transsynaptic labeling by up to
3-fold relative to the SAD B19 glycoprotein. Furthermore, oG, a
codon-optimized version of PBG, resulted in an additional 4- to
9-fold improvement for an overall improvement of up to 20-fold
relative to the original SAD B19 glycoprotein. This reagent there-
fore provides a more powerful means to identify and study brain-
wide presynaptic inputs to neurons of interest.
To improve G-deleted rabies tracing efficiency, we first
compared glycoproteins derived from different rabies strains
before then using codon optimization to increase the expression
levels of the best glycoprotein. Based on previous examples of
successful improvements in various applications, particularly
for lentiviruses pseudotyped with rabies glycoproteins (Hirano
et al., 2013; Kato et al., 2011a, 2011b), we chose to investigate
chimeric glycoproteins based on the CVS-N2C and Pasteur
rabies viruses. In the case of Pasteur strain-derived G (PBG),
we observed significant improvement of transsynaptic effi-
ciency. In contrast, we did not observe any statistically signifi-
cant improvement when usingCVS-N2C-derivedG (NBG). There
are several possible reasons for this difference. First, it is
possible that CVS-N2C G does not mediate uptake at axon ter-
minals as efficiently as the Pasteur virus G. However, it is also
possible that the chimeric CVS-N2C G (NBG) does not interact696 Cell Reports 15, 692–699, April 26, 2016efficiently with the SAD B19 viral core,
despite incorporation of the SAD B19
transmembrane/cytoplasmic domain, or
that the NBG chimeric protein compro-
mises the native ability of CVS-N2C G tomediate infection of axon terminals. This last possibility is
considered further (see below) in the context of a recent study
utilizing the CVS-N2C strain of RVdG for transsynaptic tracing
(Reardon et al., 2016). It should be also noted that glycoprotein
variants derived from other untested rabies virus strains might
enhance the transsynaptic efficiency even more effectively.
Future studies should investigate other strains that have not
been included in this study. It also remains to be understood
by which mechanism PBG improves circuit tracing with the
RVdG trans-complementation system: packaging efficiency, up-
take efficiency, or other factors. Detailed functional assessments
of rabies biology at each step should be undertaken to assess
these questions.
We aimed to further improve transsynaptic labeling efficiency
by using codon optimization forM. musculus to produce oG and
increase expression levels of the chimeric PBG rabies glycopro-
tein in starter cells. This resulted in a four- to nine-fold improve-
ment in transsynaptic labeling, adding further support to the
hypothesis that glycoprotein expression should be maximized
for efficient tracing (Miyamichi et al., 2013; Watabe-Uchida
et al., 2012). In previous experiments, this has been achieved
through the use of stronger promoters in helper viruses (Miyami-
chi et al., 2013) or by expressing G independently of other genes
(e.g., TVA and/or fluorescent proteins) that are typically used in
RVdG tracing experiments; separate helper viruses are used
for expressing G and other proteins rather than linking genes
with 2A elements, since 2A elements appear to reduce expres-
sion levels (Wall et al., 2010; Watabe-Uchida et al., 2012).
Here, we incorporated both nuclear GFP and oG, linked by 2A el-
ements, into the same helper virus in order to facilitate accurate
and unambiguous quantification of starter cells. We therefore
expect that expression levels and efficiency of transsynaptic
spread would be improved still further by using a helper virus in
which oG is expressed independently. Future studies would
benefit from a high-quality, specific, and sensitive antibody
against rabies glycoprotein, obviating the need for expression
of a linked fluorescent protein to indicate cells expressing G. It
should also be noted that the AAV vector used for expression
of oG had a 25% lower titer than for the other glycoproteins
tested. While this difference is modest, there is probably not a
linear relationship between viral titer and transduction efficiency
(Nathanson et al., 2009). It is therefore possible that the improve-
ment in gene expression levels and transsynaptic labeling
achieved by codon optimization (oG versus PBG) might be
somewhat greater than indicated by the direct comparison of
our results.
It has recently been reported that RVdG derived from the CVS-
N2C strain of rabies virus has roughly 10- to 20-fold better trans-
synaptic tracing efficiency than the original system using SAD
B19 rabies virus (Reardon et al., 2016). This improvement is
similar to the improvement that we have demonstrated here
based on modifications to the glycoprotein used for trans-
complementation of SAD B19 RVdG. Taken at face value, this
would suggest the two systems are similar in tracing efficiency
and that the choice of system for use might be based on other
factors such as convenience of virus production (easier for
SAD B19), cytotoxicity and survival times (less and longer for
CVS-N2C), or speed and levels of gene expression (faster and
higher for SAD B19). However, it is difficult to predict relative
transsynaptic efficiency of these different systems (CVS-N2C
versus SAD B19 with oG) that might be observed with direct
comparisons. Differences in receptors that mediate rabies virus
uptake from axon terminals of different cell types might result in
different relative efficiencies depending on the circuits being
investigated. Our experiments comparing different glycopro-
teins in the context of SAD B19 RVdG were conducted in
different circuits (thalamocortical circuits in our study) than those
comparing CVS-N2C to SAD B19 (corticostriatal or premotor-
motor neuronal circuits). Future studies should not only make
direct comparisons of the same circuits but also explore the
mechanisms responsible for any differences observed in order
to facilitate further improvements in both systems.
In comparing these systems, it is noteworthy that use of the
chimericglycoproteinNBG,derived fromtheextracellular domain
of the CVS-N2C glycoprotein, did not improve transsynaptic effi-
ciency. While this might suggest that differences in efficiency be-
tween the original SAD B19 RVdG system and the CVS-N2C
RVdG system are not due to improved uptake mediated by the
N2C glycoprotein, this might not be the case. As noted above, it
is possible that the chimeric NBG glycoprotein might fail to
conserve the structure of the extracellular domain required for
efficient uptake and would therefore perform worse than the
native N2C glycoprotein when used to trans-complement CVS-
N2C RVdG. Without such disruption (if present), it is theoretically
possible that the native N2C glycoprotein might mediate viral up-
take by axon terminals as efficiently as Pasteur strain glycopro-
tein. This possibilitymight be tested directly by comparing tracing
efficiencywith thenativeN2Cglycoprotein versusNBGglycopro-
tein in the context of the SADB19 strain of RVdG. It would also be
informative to generate a chimeric Pasteur strain-N2C glycopro-tein for trans-complementation of CVS-N2C RVdG and test
whether it can further improve transsynaptic spread of that strain.
Finally, Reardon et al. also compared the health of cells in-
fectedwith CVS-N2CRVdG versus SADB19RVdG and reported
that when potentially toxic gene products (ChR2 or GCaMP) are
expressed, CVS-N2C RVdG-infected cells are healthier. It is
important to note that this difference is not likely to be related
to tracing efficiency. They demonstrate toxic effects at early
time points post-infection. But SAD B19 RVdG is not toxic at
these time points when non-toxic gene products such as GFP
are expressed (Wickersham et al., 2007a). The differences in
toxicity may instead be attributed to differences in gene expres-
sion between the two viral strains; since CVS-N2C RVdG re-
quires more time to express transgenes at high levels, the toxic
effects of transgenes are not apparent as quickly (Reardon et al.,
2016). It is also possible that differences in toxicity were related
to the 50- to 100-fold higher viral titers used for SAD B19 RVdG.
Previous studies have demonstrated that increased levels of
glycoprotein expression from rabies virus do not increase path-
ogenicity (Wirblich and Schnell, 2011) and we have not observed
any signs of increased toxicity when using oG.
It would also be useful to investigate whether oG can be used
to improve other procedures and applications that are based on
SAD B19 RVdG. If oG enhances the efficiency of rabies uptake
by presynaptic neurons, oG+RVdGmight function as amore effi-
cient retrograde viral tracer than B19G+RVdG. It would therefore
be interesting to examine not only whether oG+RVdGmight label
more input neurons but also whether it might spread to neurons
that were not labeled when using B19G+RVdG. oG should also
be a valuable reagent for recovering new RVdG variants from
plasmid DNA (Osakada and Callaway, 2013; Osakada et al.,
2011). To rescue the RVdG from plasmid DNA, current systems
use cell lines stably expressing B19G and T7 RNA polymerase,
such as the B7GG cell line (Osakada et al., 2011). If oG can
improve packaging efficiency of SAD B19 in producer cells, it
should also enhance virus production, resulting in higher titers
of RVdG. This approach might be particularly useful in cases
when the recovery of rabies variants has been difficult (Osakada
et al., 2011) or when rabies with high titer is required, for
example, for single-cell network tracing (Marshel et al., 2010;
Wertz et al., 2015). In summary, with its simplicity and versatility,
oG should provide strong advantages for the study of neural cir-
cuits and is expected to have a broad range of applications.
EXPERIMENTAL PROCEDURES
Transgenic Mice
All experimental procedures were approved by the Salk Institute Animal Care
and Use Committee. PVIRES-Cre/+, Tlx3-Cre PL56, and R26LSL-TVA/+ mouse
lines have been described previously (Gerfen et al., 2013; Hippenmeyer
et al., 2005; Seidler et al., 2008). Briefly, PVIRES-Cre/+ and Tlx3-Cre PL56mouse
lines express Cre only in PV+ neurons or cortical layer 5 pyramids, respectively,
whereas R26LSL-TVA/+ is a responder line expressing TVA in a Cre-dependent
manner. Homozygous PVIRES-Cre/IRES-Cre and R26LSL-TVA/LSL-TVA mice were
bred to produce PVIRES-Cre/+;R26LSL-TVA/+ mice.
Chimeric Glycoprotein Design
NBG was cloned to consist of the extracellular domain of CVS-N2C rabies G
and transmembrane/cytoplasmic domain of SAD B19G, using pCAGGS-
FuG-B (Kato et al., 2011a) and pHCMV-B19G (Sena-Esteves et al., 2004),Cell Reports 15, 692–699, April 26, 2016 697
respectively. PBG was cloned to consist of the extracellular domain of Pasteur
strain rabies G and transmembrane/cytoplasmic domain of SAD B19G, using
pCAGGS-FuG-B2 (Kato et al., 2011a) and pHCMV-B19G (Sena-Esteves et al.,
2004), respectively. oG was codon optimized from PBG for M. musculus
(Genscript).
Virus Preparation
Four different helper viruses were produced through the Salk Viral Vector core:
AAV8.EF1a.FLEX.H2B-GFP-F2A-G.WPRE.hGH (AAV-FLEX-H2B-GFP-2A-G)
expressing each rabies glycoprotein in a Cre-dependent manner. Four kinds
of AAV-FLEX-H2B-GFP-2A-G express different glycoprotein variants: B19G,
NBG, PBG, or oG each. Titers of AAVs expressing B19G, NBG, or PBG
were adjusted to 1.5 3 1012 GC/ml, whereas the titer of AAV expressing oG
was 1.15 3 1012 GC/ml. EnvA-pseudotyped G-deleted rabies virus,
EnvA+RVdG-dsRed with the titer of 3.6 3 107 infectious units (IU)/ml,
EnvA+RVdG-GFP (4.3 3 108 IU/ml), and EnvA+RVdG-H2B-mCherry (1.6 3
108 IU/ml) were produced following a published protocol (Osakada and Call-
away, 2013). The plasmid pAAV-FLEX-H2B-GFP-2A-oG, as well as additional
plasmids for expressing oG, have been deposited at Addgene and AAVs can
be purchased from the Salk Viral Vector Core.
Animal Surgery for Virus Injection
PVIRES-Cre/+;R26LSL-TVA/+ mice received AAV helper injections at P38–P78.
Mice were anaesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine
cocktail via intraperitoneal injections and mounted in a stereotax (Model 940
series, David Kopf Instruments) for surgery and stereotaxic injections. Virus
was injected into the center of V1, using the following coordinates: 3.4 mm
rostral, 2.6 mm lateral relative to bregma, and 0.5–0.7 mm ventral from the
pia. We injected 100 nl AAVs using air pressure by picospritzer (General Valve
Corp). To prevent virus backflow, the pipette was left in the brain for 5–10 min
after completion of injection. Two or three weeks after AAV helper injection,
200 nl 5-fold-diluted EnvA+RVdG-dsRed (7.2 3 106 IU/ml) was injected into
the same site in V1 using picospritzer-mediated air pressure. For control ex-
periments, PVIRES-Cre/+;R26LSL-TVA/+ or Tlx3-Cre/+;R26LSL-TVA/+ mice received
200 nl EnvA+RVdG-GFP or EnvA+RVdG-H2B-mCherry injections at P70,
respectively, and no helper virus was injected. Mice were housed for 7 days
to allow for transsynaptic rabies spread and fluorescent protein expression.
Histology and Image Analysis
Brains were harvested after transcardial perfusion using PBS followed by 4%
paraformaldehyde (PFA). Brains were dissected out from skulls and post-fixed
with 2% PFA and 15% sucrose in PBS at 4C for 16–20 hr, then immersed in
30% sucrose in PBS at 4C before sectioning. 50-mm coronal brain sections
were prepared using a freezing microtome and stored in PBS with 0.01% so-
dium azide at 4C. To label PV+ neurons, free-floating sections were incubated
at 4C for 16–48 hr with mouse anti-PV (1:1,000, P3088; Sigma-Aldrich) pri-
mary antibodies in PBS/0.5% normal donkey serum/0.1% Triton X-100, fol-
lowed by the appropriate secondary antibodies conjugated with Alexa 647
(Molecular Probes) at room temperature for 2–3 hr. Sections were counter-
stained with 10 mM DAPI in PBS for 30 min to visualize cell nuclei. Immuno-
stained tissue sections were mounted on slides with polyvinyl alcohol
mounting medium containing DABCO and allowed to air-dry overnight.
Confocal imaging was performed with Zeiss LSM780 confocal microscope.
Confocal images were processed and analyzed in NIH ImageJ software (FIJI).
For rabies tracing analysis, every 50-mm coronal section from bregma
1.34 mm to 5.20 mm was collected. Individual tissue sections were
scanned with a 103 objective using Olympus VS120 slide scanner or were
directly examined with Olympus BX51 microscope. Cell counts and re-
gistrations were acquired using OlyVIA 2.6 software provided by Olympus.
The section was then registered again using The Mouse Brain in Stereotaxic
Coordinates atlas (Paxinos et al., 2001) fit to the scanned image using the first
registration as a guide to adjust for minor tissue variation or deformation.
Borders based on nuclear counterstain density were then added to denote
layer boundaries. Lastly, dsRed and GFP channels were turned on, and cell
counts were recorded for each brain region.
For starter cell location analysis along the anterior-posterior axis, center of
gravity analysis was performed byweighting starter neuron count for each cor-698 Cell Reports 15, 692–699, April 26, 2016onal sections of V1 at the bregma stereotaxic coordinates, where center of
gravity = S (number of starter neurons3 bregma)/S number of starter neurons.
For distribution analysis of starter neurons along the dorsoventral axis, we
used custom-made MATLAB code to calculate the proportion of starter neu-
rons per bin from the pia to the white matter after dividing them into 11 bins.
Statistical Analysis
For analysis of starter neuron distribution, a Kruskal-Wallis test with Dunn’s
multiple comparisons test as a post hoc was used with all values reported
as the median. For rabies traced input analysis, a one-tailed Mann-Whitney
test was used for comparisons with all values reported as the mean ± SEM.
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